Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$181.63B | 46.3x | 0.06 | NT$545 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.3% Upside | Upgrade to Pro+ | |
Bora Pharmas | Taiwan | Healthcare | Pharmaceuticals | NT$86.16B | 14.3x | 0.24 | NT$833 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20% Upside | Upgrade to Pro+ | |
Lotus Pharma | Taiwan | Healthcare | Pharmaceuticals | NT$58.37B | 10.7x | 0.28 | NT$223 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.5% Upside | Upgrade to Pro+ | |
Oneness Biotech | TPEX | Healthcare | Pharmaceuticals | NT$31.42B | -25.5x | 3.13 | NT$65.70 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$30.05B | -10.7x | 0.17 | NT$39 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Center Laboratories | TPEX | Healthcare | Pharmaceuticals | NT$26.92B | -2,000x | -19.81 | NT$37.80 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$23.62B | -111.6x | 2.22 | NT$86.50 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.9% Upside | Upgrade to Pro+ | |
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$23.47B | -55.3x | -3.13 | NT$139 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pegavision | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$23.40B | 12.9x | -2.36 | NT$300 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23% Upside | Upgrade to Pro+ | |
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$22.66B | 31.2x | 3.68 | NT$416 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
EirGenix | TPEX | Healthcare | Pharmaceuticals | NT$19.92B | -26.8x | -3.39 | NT$65.90 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TTY Biopharm | TPEX | Healthcare | Pharmaceuticals | NT$18.70B | 12x | 0.36 | NT$75.20 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.6% Upside | Upgrade to Pro+ | |
Synmosa Biopharma | TPEX | Healthcare | Pharmaceuticals | NT$17.77B | 23.4x | 3.71 | NT$35.50 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.9% Downside | Upgrade to Pro+ | |
Universal Vision BioTech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$16.86B | 15x | 4.1 | NT$199 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | |
Y.S.H. | Taiwan | Healthcare | Pharmaceuticals | NT$16.54B | 13.5x | 0.4 | NT$62.10 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen Vaccine Biologics | TPEX | Healthcare | Pharmaceuticals | NT$13.87B | -493.6x | -5.01 | NT$42.20 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Excelsior | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$13.82B | 17.7x | 2.55 | NT$84.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.7% Upside | Upgrade to Pro+ | |
SPT | Taiwan | Healthcare | Pharmaceuticals | NT$13.36B | 54.5x | -1.5 | NT$16.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42% Upside | Upgrade to Pro+ | |
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$13.30B | -195x | -5.89 | NT$108.50 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Handa Pharmas | TPEX | Healthcare | Pharmaceuticals | NT$13.01B | 24.4x | -0.72 | NT$82.20 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lin Bio | TPEX | Healthcare | Pharmaceuticals | NT$12.78B | -14.6x | 8.33 | NT$163 | 11.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$12.59B | -6.6x | -0.2 | NT$52.80 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taidoc Tech | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$11.97B | 16.2x | -0.58 | NT$125.50 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$11.43B | -8.3x | 0.45 | NT$73.80 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$11.14B | 6.3x | 0.01 | NT$77.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medeon Biodesign | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$10.78B | -13.8x | -0.39 | NT$117 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
SCPC | Taiwan | Healthcare | Pharmaceuticals | NT$10.40B | 12.6x | -2.07 | NT$58.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.4% Upside | Upgrade to Pro+ | |
United Orthopedic | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$10.17B | 18.4x | 0.59 | NT$105.50 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.4% Upside | Upgrade to Pro+ | |
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$8.94B | -3.6x | 0.05 | NT$34 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CHO Pharma | TPEX | Healthcare | Pharmaceuticals | NT$8.55B | -40.3x | -1.06 | NT$39.95 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |